Genetics of redox systems and their relationship with cardiovascular disease

Dan Farbstein1, Yitzchak Z Soloveichik, Nina S Levy

  • 1The Ruth and Bruce Faculty of Medicine, Technion Israel Institute of Technology, Efron St., POB 9649, Haifa 31096, Israel. dfarb@tx.technion.ac.il

Insights

Identifying genetic variations linked to oxidative stress is key for early cardiovascular disease (CVD) risk assessment. This study examines six key gene polymorphisms impacting CVD risk, protein function, and potential pharmacogenetics.

Area of Science:

  • Genetics and Cardiovascular Medicine
  • Molecular Biology and Disease Mechanisms

Background:

  • Atherosclerosis remains a leading cause of mortality in Western populations.
  • Oxidative stress is recognized as a critical factor in atherosclerosis development and progression.
  • Genetic polymorphisms in redox-related genes are investigated for their association with cardiovascular disease (CVD) risk.

Purpose of the Study:

  • To evaluate the impact of six specific gene polymorphisms on CVD risk.
  • To analyze the effects of these polymorphisms on protein expression and function.
  • To discuss the pharmacogenetic implications associated with these genetic variations.

Main Methods:

  • Review and analysis of existing studies on six selected gene polymorphisms.
  • Examination of data linking polymorphisms to CVD risk across different trials.
  • Assessment of polymorphism effects on protein expression and functional activity.

Main Results:

  • A limited number of polymorphisms consistently show relevance to CVD risk.
  • Specific polymorphisms influence protein expression and function, contributing to disease risk.
  • Pharmacogenetic data, where available, highlights potential treatment implications.

Conclusions:

  • Certain gene polymorphisms related to redox systems are significantly associated with cardiovascular disease risk.
  • Understanding these genetic factors can aid in identifying high-risk individuals for early intervention.
  • Further research into pharmacogenetics of these polymorphisms may personalize CVD treatment strategies.

Related Concept Videos

Redox Reactions01:27

Redox Reactions

Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
Redox Reactions01:24

Redox Reactions

Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
Redox Equilibria: Overview01:23

Redox Equilibria: Overview

A reduction-oxidation reaction is commonly called a redox reaction. In a redox reaction, electrons are transferred from one species to another rather than being shared between or among atoms. The reducing agent or reductant is the species that loses electrons and gets oxidized in the process. The species that gains electrons and gets reduced in the process is the oxidizing agent or oxidant. Redox reactions are represented as two separate equations called half-reactions, where one equation...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
Oxidation and Reduction of Organic Molecules01:19

Oxidation and Reduction of Organic Molecules

Energy production within a cell involves many coordinated chemical pathways. Most of these pathways are combinations of oxidation and reduction reactions, which occur at the same time. An oxidation reaction strips an electron from an atom in a compound, and the addition of this electron to another compound is a reduction reaction. Because oxidation and reduction usually occur together, these pairs of reactions are called redox reactions.
The removal of an electron from a molecule, results in a...